Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.2.0.727
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2015
Dec. 31, 2014
Assets    
Financing receivables $ 688,632 $ 552,706
Financing receivables held-for-sale 85,461 62,275
Investments available-for-sale 28,455 27,273
Real estate 126,683 90,907
Real estate related intangible assets 25,482 23,058
Equity method investments in affiliates 161,648 143,903
Cash and cash equivalents 21,670 58,199
Restricted cash and cash equivalents 12,911 11,943
Other assets 30,502 39,993
Total Assets 1,181,444 1,010,257
Liabilities:    
Accounts payable, accrued expenses and other 13,749 11,408
Deferred funding obligations 95,700 88,288
Credit facility 420,496 315,748
Asset-backed nonrecourse notes (secured by assets of $230 million and $248 million, respectively) 197,694 208,246
Other nonrecourse debt (secured by financing receivables of $104 million and $108 million, respectively) 107,510 112,525
Total Liabilities $ 835,149 $ 736,215
Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding    
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 31,221,982 and 26,377,111 shares issued and outstanding, respectively $ 312 $ 264
Additional paid in capital 379,183 293,635
Retained deficit (37,131) (25,006)
Accumulated other comprehensive (loss) income (81) 406
Non-controlling interest 4,012 4,743
Total Equity 346,295 274,042
Total Liabilities and Equity $ 1,181,444 $ 1,010,257